Clarifying the Role of Psychomotor Retardation in Reward-Based Reinforcement Learning Deficits in MDD: A Computational and fMRI Study
Clarifying the Role of Psychomotor Retardation in Reward-Based Reinforcement Learning Deficits in MDD: A Computational and fMRI Study
批准号:
10591880
负责人:
Allison Letkiewicz
金额:
$18.16万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-12-15 至 2027-11-30
关键词:
AdultAgeAntidepressive AgentsApplications GrantsAwardBasal GangliaBehaviorBehavioralBlood flowClinicalCognitiveComputer ModelsCorpus striatum structureDataDiagnostics ResearchDiseaseDisease remissionDorsalExhibitsFunctional Magnetic Resonance ImagingFutureGoalsGrainGrantImpairmentIndividualInterviewK-Series Research Career ProgramsKnowledgeLaboratoriesLearningLifeMajor Depressive DisorderMeasuresMental DepressionMental disordersMentorsMentorshipMethodsMotorNeurobiologyOutcomeParameter EstimationParkinson DiseasePlayPrincipal InvestigatorProcessPsychological reinforcementPsychomotor PerformancePsychopathologyRecurrenceReportingResearchResearch Domain CriteriaResearch MethodologyResearch PersonnelResearch Project GrantsRestRewardsRoleSchizophreniaScientistSpeedSymptomsSystemTask PerformancesTestingTrainingTraining ActivityUnited States National Institutes of HealthUniversitiesVentral Striatumbehavior predictioncareerclinically relevantclinically significantcognitive processcostdepressive symptomsexperienceinnovationneuralneural circuitneural correlateneuroimagingpreventprospectiveresponseskillssocialtreatment response
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Major depressive disorder (MDD) is a highly prevalent and costly mental health disorder. A potentially important
contributor to MDD is impaired reward-based reinforcement learning (RBRL). RBRL are a set of processes
reflecting difficulty learning which actions are likely to lead to rewarding outcomes, and are clinically significant
features of MDD that predicts future depressive symptoms and worse treatment response. MDD, however, is
heterogeneous and RBRL may relate to particular MDD symptoms - specifically psychomotor retardation
(PmR), a vastly understudied but impairing aspect of MDD that may be especially detrimental for RBRL. Despite
overlapping neural circuitry between PmR and RBRL, no study has assessed the impact of PmR on RBRL-
related behavior and neural activity in MDD. This is a critical question, as the degree to which RBRL is impaired
and which RBRL processes are altered in MDD may depend on PmR. Furthermore, this is highly clinically
relevant as ameliorating RBRL deficits related to PmR in MDD may depend on targeting specific RBRL
processes. Thus, the overall goal of the proposed K23 is to clarify the role of PmR on RBRL deficits in MDD
using innovative computational modeling to parse specific RBRL processes and fMRI. Building on an ongoing
R01 (PIs: Dr. Shankman, Mittal, Walther [mentors on this K23]), Aim 1 will test whether experimentally
manipulating the demand for psychomotor speed impacts behavioral and neural indicators of RBRL in individuals
(ages 18-60) with MDD (N=66) vs. healthy controls (N=44). Aim 2 will test whether a fine-grained laboratory
assessment of PmR in MDD predicts behavioral and neural indicators of RBRL, and whether associations
between PmR and RBRL are stronger when faster psychomotor speed is required. Aim 3 will examine whether
PmR-related RBRL impairment in MDD predicts the course of depression over 1-year. The proposed career
development award also aims to provide Dr. Letkiewicz with experiences and training activities that will support
her goals of increasing her knowledge of (1) the neural and behavioral basis of psychomotor functioning in MDD,
(2) advanced computational modeling to assess reinforcement learning in the context of psychomotor symptoms,
(3) multimethod RDoC approaches to studying mechanisms of psychopathology, and (4) grantsmanship and
mentorship skills. Her training goals will primarily be accomplished through formal didactics, training with her
mentorship team, and the interdisciplinary centers and institutes at Northwestern University. Her mentorship
team consists of leading experts in MDD and transdiagnostic research (Dr. Shankman), reinforcement learning
and computational modeling (Dr. Kahnt), neuroimaging and motor systems (Dr. Mittal), and psychomotor
assessment (Dr. Walther), all of whom have all have active NIH grants and an excellent track record of mentoring
early career scientists. This award will prepare Dr. Letkiewicz to submit an R01 grant application and provide
her with the skills needed to achieve her long-term career goal of examining the unique and combined
contribution of cognitive and motor systems to psychopathology as an independent clinical scientist.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: